{"comparisonGroups":["RU- Control","RU+ Switch"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs RU+ switch treatment","group_a_title":"Control group with no RU treatment. Serves as a baseline for comparison with treated samples","group_b_title":"Treated group with RU+ switch. Represents the effect of RU+ switch treatment","id":"MTBLS3251_0001_00000006","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":135,"studyId":"MTBLS3251","studyUrl":"http://integmet.org/study/MTBLS3251","title":"RU-_Control_vs_RU+_Switch","topHits":[{"chebi_id":"179765","direction":"up","inn_name":"","iupac_name":"[(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropyl] (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate","metabolite_id":"LSMZHQKGKWMNRR-TWSQBWPKSA-N","pvalue":6.36751433829118e-05,"ratio":3.1366284182971373,"synonym_name":""},{"chebi_id":"179764","direction":"up","inn_name":"","iupac_name":"[(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-[(Z)-heptadec-9-enoyl]oxypropyl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate","metabolite_id":"GHHCEXBJBUVAMW-XMMSBNOZSA-N","pvalue":6.36751433829118e-05,"ratio":3.1366284182971373,"synonym_name":""},{"chebi_id":"169778","direction":"up","inn_name":"","iupac_name":"[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate","metabolite_id":"CTRNSVCYDUIICT-FFLBNGNKSA-N","pvalue":6.36751433829118e-05,"ratio":3.1366284182971373,"synonym_name":""},{"chebi_id":"179763","direction":"up","inn_name":"","iupac_name":"[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropan-2-yl] (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate","metabolite_id":"VKGJBKWFGHBXMN-ITYCCWCBSA-N","pvalue":6.36751433829118e-05,"ratio":3.1366284182971373,"synonym_name":""},{"chebi_id":"179762","direction":"up","inn_name":"","iupac_name":"[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-[(Z)-heptadec-9-enoyl]oxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate","metabolite_id":"WSXPDGFXIPEFAL-KRTJINJGSA-N","pvalue":6.36751433829118e-05,"ratio":3.1366284182971373,"synonym_name":""},{"chebi_id":"179761","direction":"up","inn_name":"","iupac_name":"[(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-pentadecanoyloxypropyl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate","metabolite_id":"RMNLEOBVQMZLCN-JHFOFQKASA-N","pvalue":6.36751433829118e-05,"ratio":3.1366284182971373,"synonym_name":""},{"chebi_id":"169501","direction":"down","inn_name":"","iupac_name":"S-methyl benzenecarbothioate","metabolite_id":"RQVWTMCUTHKGCM-UHFFFAOYSA-N","pvalue":0.0002420897582137,"ratio":0.3266665274318644,"synonym_name":""},{"chebi_id":"177818","direction":"up","inn_name":"","iupac_name":"3-(3-hydroxypentadecanoyloxy)-4-(trimethylazaniumyl)butanoate","metabolite_id":"WJVDXGQFPKCLCW-UHFFFAOYSA-N","pvalue":0.0002258902215153,"ratio":2.644704753030376,"synonym_name":""},{"chebi_id":"79848","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"BQIBBYLXJDSLIR-FTQGCKHGSA-N","pvalue":0.0002258902215153,"ratio":2.644704753030376,"synonym_name":"3beta,17beta-Diacetoxy-5alpha-androstane"},{"chebi_id":"74966","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-3-(dodecanoyloxy)-2-hydroxypropyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"BWKILASWCLJPBO-LJQANCHMSA-N","pvalue":0.0002258902215153,"ratio":2.644704753030376,"synonym_name":"1-lauroyllysophosphatidylcholine"}],"totalFeatures":3481}